# Empaveli

NDC: 73606-010
Generic name: Pegcetacoplan
Labeler / Manufacturer: Apellis Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20210514

FDA application: NDA215014

## Active ingredients

- PEGCETACOPLAN: 1080 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73606-010"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73606-010
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c23d89e9-b00b-4520-e053-2995a90a95af